Coronado Biosciences to Report Second Quarter 2012 Financial Results
Published: Aug 01, 2012
BURLINGTON, Mass., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, announced today that it will report its financial results for the second quarter 2012, on Wednesday, August 8, 2012 at 8:30 AM ET. To participate in the conference call, please dial (877) 312-5413 (toll free from the US and Canada), or (253) 237-1511 (for international callers). Investors may also access a live audio webcast of the call at http://www.coronadobiosciences.com/ on the Events & Webcasts page.